Yinghan Su

机构：Fudan University, Fudan University Shanghai Cancer Center, Huashan Hospital · ORCID：0000-0002-1141-0668

发表论文 31 篇 · 总被引 578 次 · h-index 13

代表论文

• Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma (2022 · Cancer Research · 被引 178)
• Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma (2020 · Lung Cancer · 被引 89)
• Current landscape and perspective of oncolytic viruses and their combination therapies (2022 · Translational Oncology · 被引 36)
• Emerging Regulatory Mechanisms of N6-Methyladenosine Modification in Cancer Metastasis (2022 · Phenomics · 被引 27)
• Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors (2022 · Journal for ImmunoTherapy of Cancer · 被引 19)
• Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer (2020 · Pathobiology · 被引 14)